Michael J. Bohanon

Publications by Year

Research Areas

Peptidase Inhibition and Analysis, Antibiotic Resistance in Bacteria, HIV/AIDS drug development and treatment, Bacteriophages and microbial interactions, Cancer therapeutics and mechanisms

Most-Cited Works

• → Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class(1998)295 cited
• → Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potentd-Amino Acid Oxidase (DAAO) Inhibitors(2009)109 cited
• → 3-Arylpiperidines as potentiators of existing antibacterial agents(2001)56 cited
• → Localization of Separate Genetic Loci for Reduced Sensitivity towards Small Isometric-Headed Bacteriophage sk1 and Prolate-Headed Bacteriophage c2 on pGBK17 from Lactococcus lactis subsp. lactis KR2(1989)35 cited
• → Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition(2001)29 cited
• → Soluble CD4-PE40 Is Cytotoxic for a Transfected Mammalian Cell Line Stably Expressing the Envelope Protein of Human Immunodeficiency Virus (HIV-1), and Cytotoxicity Is Variably Inhibited by the Sera of HIV-1-Infected Patients(1991)13 cited
• → Immobilization of a Novel Antibacterial Agent on Solid Phase and Subsequent Isolation of EF-Tu(2004)9 cited
• → Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates(2017)9 cited
• → Isolation of Auxotrophic Mutants of Methylophilus methylotrophus by Modified-Marker Exchange(1988)9 cited
• → Corrigendum to “Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition” [Bioorg. Med. Chem. Lett. 11 (2001) 1355]†(2001)3 cited